ICD-10-CM Billable Code

T44.3X1

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional)

Clinical Classification Guidelines

Inclusion Terms

  • Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics NOS

Medical Intelligence & Overview

Poisoning by parasympatholytics, anticholinergics, antimuscarinics, and spasmolytics refers to an unintentional exposure to medications that block the parasympathetic nervous system. These drugs are used for various medical conditions, but accidental ingestion or overdose can lead to poisoning. This document provides an overview geared toward patient understanding of such incidents, including causes, symptoms, diagnosis, and typical treatment approaches.

Causes & Symptoms

Clinical Causes: Accidental ingestion of medications containing anticholinergic or antimuscarinic agents, often by children or individuals confused about their medication regimens. Incorrect dosage administration, for example, taking too much of a prescribed medication. Accidental exposure to spasmolytics or other parasympatholytic drugs through improper handling or storage. Medication errors like mixing up drugs or taking them from containers not properly labeled. Use of over-the-counter medications that contain parasympatholytic components without proper awareness.

Key Symptoms: Dry mouth and throat Blurred vision Dizziness or lightheadedness Rapid heartbeat or palpitations Urinary retention or difficulty urinating Constipation Confusion or hallucinations, especially in older adults Dilated pupils and sensitivity to light Flushing and skin dryness Fever and decreased sweating

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a healthcare professional assessing the patient's medical history, symptoms, and possible exposure to parasympatholytic medications. Laboratory tests may include blood work to identify the presence of the medication or its metabolites in the bloodstream. Clues from physical examination, such as ocular and skin findings, help confirm the suspicion of anticholinergic toxicity.

Treatment Protocols: Management of poisoning cases generally involves supportive care aimed at stabilizing vital signs and facilitating elimination of the toxin. Specific interventions may include: - Absorption reduction procedures like activated charcoal administration - Hydration and electrolyte management - Monitoring cardiac function and vital signs closely - Use of specific antidotes such as physostigmine in certain cases - Preventative measures to avoid re-exposure, including patient education and secure medication storage Hospitalization may be required depending on severity, and caregivers are advised to seek immediate medical attention if poisoning is suspected.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T44.3X1 a billable ICD-10 code?
Yes, T44.3X1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T44.3X1?
Clinical documentation must specify the nature of Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional) and any associated comorbidities for accurate reporting.

Cite this Clinical Reference